Logotipo del repositorio
Logotipo del repositorio
 

Capacity for the management of kidney failure in the International Society of Nephrology Latin America region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)

Vista sencilla de ítem
datacite.rightshttp://purl.org/coar/access_right/c_14cb
dc.contributor.authorCalice-Silva, Viviane
dc.contributor.authorNeyra, Javier A.
dc.contributor.authorFerreiro Fuentes, Alejandro
dc.contributor.authorSinger Wallbach Massai, Krissia Kamile
dc.contributor.authorArruebo, Silvia
dc.contributor.authorBello, Aminu K
dc.contributor.authorCaskey, Fergus John
dc.contributor.authorDamster, Sandrine
dc.contributor.authorDonner, Jo-Ann
dc.contributor.authorJha, Vivekanand
dc.contributor.authorJohnson, David W.
dc.contributor.authorLevin, Adeera
dc.contributor.authorMalik, Charu
dc.contributor.authorNangaku, Masaomi
dc.contributor.authorOkpechi, Ikechi G.
dc.contributor.authorTonelli, Marcello
dc.contributor.authorYe, Feng
dc.contributor.authorMadero, Magdalena
dc.contributor.authorTzanno-Martins, Carmen
dc.contributor.authorAroca-Martinez, Gustavo
dc.contributor.authorRico-Fontalvo, Jorge
dc.contributor.authorRegional Board and ISN-GKHA Team Authors
dc.date.accessioned2024-09-23T21:48:17Z
dc.date.available2024-09-23T21:48:17Z
dc.date.issued2024
dc.description.abstractSuccessful management of chronic kidney disease (CKD) in Latin America (LA) continues to represent a challenge due to high disease burden and geographic disparities and difficulties in terms of capacity, accessibility, equity, and quality of kidney failure care. Although LA has experienced significant social and economic progress over the past decades, there are still important inequities in health care access. Through this third iteration of the International Society of Nephrology Global Kidney Health Atlas, the indicators regarding kidney failure care in LA are updated. Survey responses were received from 22 of 31 (71%) countries in LA representing 96.5% of its total population. Median CKD prevalence was 10.2% (interquartile range: 8.4%–12.3%), median CKD disability-adjusted life year was 753.4 days (interquartile range: 581.3–1072.5 days), and median CKD mortality was 5.5% (interquartile range: 3.2%–6.3%). Regarding dialysis modality, hemodialysis continued to be the most used therapy, whereas peritoneal dialysis reached a plateau and kidney transplantation increased steadily over the past 10 years. In 20 (91%) countries, >50% of people with kidney failure could access dialysis, and in only 2 (9%) countries, people who had access to dialysis could initiate dialysis with peritoneal dialysis. A mix of public and private systems collectively funded most aspects of kidney replacement therapy (dialysis and transplantation) with many people incurring up to 50% of out-of-pocket costs. Few LA countries had CKD/ kidney replacement therapy registries, and almost no acute kidney injury registries were reported. There was large variability in the nature and extent of kidney failure care in LA mainly related to countries’ funding structures and limited surveillance and management initiatives.eng
dc.format.mimetypepdf
dc.identifier.doihttps://doi.org/10.1016/j.kisu.2024.01.001
dc.identifier.issn21571716 (Electrónico)
dc.identifier.issn21571724 (Impreso)
dc.identifier.urihttps://hdl.handle.net/20.500.12442/15691
dc.identifier.urlhttps://www.sciencedirect.com/science/article/abs/pii/S2157171624000017?via%3Dihub
dc.language.isoeng
dc.publisherElsevierspa
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United Stateseng
dc.rights.accessrightsinfo:eu-repo/semantics/closedAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/
dc.sourceKidney International Supplementseng
dc.sourceVol. 13 No. 1 Año 2024spa
dc.subject.keywordsDialysiseng
dc.subject.keywordsEconomic burdeneng
dc.subject.keywordsHealth care accesseng
dc.subject.keywordsKidney diseaseeng
dc.subject.keywordsKidney replacement therapyeng
dc.subject.keywordsLatin Americaeng
dc.titleCapacity for the management of kidney failure in the International Society of Nephrology Latin America region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)eng
dc.type.driverinfo:eu-repo/semantics/article
dc.type.spaArtículo científico
dcterms.referencesLuxardo R, Ceretta L, González-Bedat M, et al. The Latin American Dialysis and Renal Transplantation Registry: report 2019. Clin Kidney J. 2021;15:425–431.eng
dcterms.referencesGBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395:709–733.eng
dcterms.referencesThe World Bank. Latin America and Caribbean; 2023. Accessed October 6, 2023. https://data.worldbank.org/region/latin-america-and-caribbeaneng
dcterms.referencesWainstein M, Bello AK, Jha V, et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Latin America. Kidney Int Suppl. 2021;11: e35–e46.eng
dcterms.referencesOrdunez P, Saenz C, Martinez R, et al. The epidemic of chronic kidney disease in Central America. Lancet Glob Health. 2014;2:e440–e441.eng
dcterms.referencesOkpechi IG, Bello AK, Levin A, Johnson DW. Update on variability in organization and structures of kidney care across world regions. Kidney Int Suppl. 2024;13:6–11.eng
dcterms.referencesThe World Bank. World Development Indicators. The world by income and region. Accessed April 8, 2022. https://datatopics.worldbank.org/ world-development-indicators/the-world-by-income-and-region.htmleng
dcterms.referencesCentral Intelligence Agency. The World Factbook. Accessed April 8, 2022. https://www.cia.gov/the-world-factbook/eng
dcterms.referencesThe Institute for Health Metrics and Evaluation. Global Burden of Disease (GBD) Study Database 2019. Accessed April 8, 2022. http://www. healthdata.org/gbdeng
dcterms.referencesThe Institute for Health Metrics and Evaluation. Global Health Data Exchange. Global expected health spending 2019-2050. Accessed April 8, 2022. https://ghdx.healthdata.org/record/ihme-data/global-expectedhealth- spending-2019-2050eng
dcterms.referencesArredondo A, Rangel R, de Icaza E. Costo-efectividad de intervenciones para insuficiencia renal crónica terminal [Cost-effectiveness of interventions for end-stage renal disease]. Rev Saude Publica. 1998;32: 556–565 [in Spanish].eng
dcterms.referencesArze Aimaretti L, Arze S. Preemptive renal transplantation-the best treatment option for terminal chronic renal failure. Transplant Proc. 2016;48:609–611.eng
dcterms.referencesArze S, Paz Zambrana S. Advances in ethical, social, and economic aspects of chronic renal disease in Bolivia. Transplant Proc. 2016;48:559–563.eng
dcterms.referencesBabakhani A, Guy SR, Falta EM, et al. Surgeons bring RRT to patients in Guyana. Bull Am Coll Surg. 2013;98:17–27.eng
dcterms.referencesBalshaw R, Machnicki G, Carreño CA, et al. Two-hour post-dose cyclosporine levels in renal transplantation in Argentina: a cost-effective strategy for reducing acute rejection. Transplant Proc. 2005;37:871–874.eng
dcterms.referencesCerdas M. Chronic kidney disease in Costa Rica. Kidney Int Suppl. 2005;(97):S31–S33.eng
dcterms.referencesGarcia P, Sánchez-Polo V. Global dialysis perspective: Guatemala. Kidney360. 2020;1:1300–1305.eng
dcterms.referencesMéndez Chacón P, Camacho Bonilla M, Vidalón Fernández A. Trasplante y comercio de organos en Peru [Kidney transplantation and organ trade in Peru]. Nefrologia. 2006;26:527–537 [in Spanish].spa
dcterms.referencesRosselli D, Rueda JD, Diaz CE. Cost-effectiveness of kidney transplantation compared with chronic dialysis in end-stage renal disease. Saudi J Kidney Dis Transpl. 2015;26:733–738.eng
dcterms.referencesSaldarriaga EM, Bravo-Zúñiga J, Hurtado-Roca Y, Suarez V. Costeffectiveness analysis of a strategy to delay progression to dialysis and death among chronic kidney disease patients in Lima, Peru. Cost Eff Resour Alloc. 2021;19:70.eng
dcterms.referencesSilva SB, Caulliraux HM, Araújo CA, Rocha E. Cost comparison of kidney transplant versus dialysis in Brazil. Cad Saude Publica. 2016;32:S0102– 311X2016000605005.eng
dcterms.referencesTorres I, Sippy R, Bardosh K, et al. Chronic kidney disease in Ecuador: an epidemiological and health system analysis of an emerging public health crisis. PLoS One. 2022;17:e0265395.eng
dcterms.referencesvan der Tol A, Lameire N, Morton RL, et al. An international analysis of dialysis services reimbursement. Clin J Am Soc Nephrol. 2019;14:84–93.eng
dcterms.referencesNerbass FB, Lima HDN, Thomé FS, et al. Brazilian dialysis survey 2020. J Bras Nefrol. 2022;44:349–357 [in English, Portuguese].eng
dcterms.referencesUnited States Renal Data System. 2019 USRDS Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2019. Accessed April 8, 2022. https:// www.niddk.nih.gov/about-niddk/strategic-plans-reports/usrds/prior-datareports/ 2019eng
dcterms.referencesWHO-ONT Global Observatory on Donation and Transplantation. Accessed April 8, 2022. http://www.transplant-observatory.org/datacharts- and-tables/eng
dcterms.referencesWorld Health Organization. The Global Health Observatory. Health workforce; 2021. Accessed April 8, 2022. https://www.who.int/data/gho/ data/themes/health-workforceeng
dcterms.referencesStudy.com. Denomme D. Latin America. Location, physical features & human geography; 2022. Accessed October 6, 2023. https://study.com/ learn/lesson/latin-america-physical-features-geography.htmleng
dcterms.referencesEconomic Commission for Latin America and the Caribbean (ECLAC), Social Panorama of Latin America and the Caribbean, 2022 (LC/PUB. 2022/15-P), Santiago; 2022. Accessed October 6, 2023. https:// repositorio.cepal.org/server/api/core/bitstreams/a1208761-efa2-4f3a-8 be9-bc9368c370c0/contenteng
dcterms.referencesCeretta M, Luxardo R, González-Bedat M, et al. WCN23-1205 kidney replacement therapy in Latin America, 2020 data. Kidney Int Rep. 2023;8(suppl 3):S300–S301.eng
dcterms.referencesVasquez-Jimenez E, Madero M. Global dialysis perspective: Mexico. Kidney360. 2020;1:534–537.eng
dcterms.referencesPecoits-Filho R, Sola L, Correa-Rotter R, et al. Kidney disease in Latin America: current status, challenges, and the role of the ISN in the development of nephrology in the region. Kidney Int. 2018;94:1069–1072.eng
dcterms.referencesPecoits-Filho R, Rosa-Diez G, Gonzalez-Bedat M, et al. Renal replacement therapy in CKD: an update from the Latin American Registry of Dialysis and Transplantation. J Bras Nefrol. 2015;37:9–13 [in English, Portuguese].eng
dcterms.referencesPecoits-Filho R, Abensur H, Cueto-Manzano AM, et al. Overview of peritoneal dialysis in Latin America. Perit Dial Int. 2007;27:316–321.eng
dcterms.referencesJuergensen E, Wuerth D, Finkelstein SH, et al. Hemodialysis and peritoneal dialysis: patients’ assessment of their satisfaction with therapy and the impact of the therapy on their lives. Clin J Am Soc Nephrol. 2006;1:1191–1196.eng
dcterms.referencesJansen MA, Hart AA, Korevaar JC, et al. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62: 1046–1053.eng
dcterms.referencesChang YT, Hwang JS, Hung SY, et al. Cost-effectiveness of hemodialysis and peritoneal dialysis: a national cohort study with 14 years follow-up and matched for comorbidities and propensity score. Sci Rep. 2016;6: 30266.eng
dcterms.referencesPan American Health Organization. Strategic plan of the Pan American Health Organization; 2014-2019. Accessed October 6, 2023. https://iris. paho.org/bitstream/handle/10665.2/7654/CD53-OD345-e.pdf? sequence¼16& isAllowed¼yeng
dcterms.referencesPan American Health Organization. Strategic plan of the Pan American Health Organization 2020-2025. Accessed October 6, 2023. https://iris. paho.org/bitstream/handle/10665.2/52473/9789275173619_eng.pdf? sequence¼5eng
dcterms.referencesGonzalez-Bedat MC, Rosa-Diez GJ. Registro Latinoamericano de Dialisis y Trasplante Renal; 2020-2021. Accessed October 6, 2023. https://slanh. net/wp-content/uploads/2023/06/informe-2021.pdfspa
dcterms.referencesCusumano AM, Rosa-Diez GJ, Gonzalez-Bedat MC. Latin American Dialysis and Transplant Registry: experience and contributions to end-stage renal disease epidemiology. World J Nephrol. 2016;5: 389–397.eng
dcterms.referencesGonzalez-Bedat M, Rosa-Diez G, Pecoits-Filho R, et al. Burden of disease: prevalence and incidence of ESRD in Latin America. Clin Nephrol. 2015;83(suppl 1):3–6.eng
dcterms.referencesNicoll R, Robertson L, Gemmell E, et al. Models of care for chronic kidney disease: a systematic review. Nephrology (Carlton). 2018;23:389– 396.eng
dcterms.referencesCusumano AM, González Bedat MC. Chronic kidney disease in Latin America: time to improve screening and detection. Clin J Am Soc Nephrol. 2008;3:594–600.eng
dcterms.referencesCorrea-Rotter R, Mendez Duran A, Vallejos A, et al. Unmet needs of CKD in Latin America: a review from Expert Virtual Working Group. Kidney Int Rep. 2023;8:954–967.eng
dcterms.referencesGonzalez-Bedat MC, Rosa-Diez GJ, Fernandez-Cean JM, et al. National kidney dialysis and transplant registries in Latin America: how to implement and improve them. Rev Panam Salud Publica. 2015;38: 254–260.eng
dcterms.referencesSola L, Plata-Cornejo R, Fernandez-Cean J. Latin American special project: kidney health cooperation project between Uruguay and Bolivia. Clin Nephrol. 2015;83(suppl 1):21–23.eng
dcterms.referencesChuengsaman P, Kasemsup V. PD First Policy: Thailand’s response to the challenge of meeting the needs of patients with end-stage renal disease. Semin Nephrol. 2017;37:287–295.eng
dcterms.referencesKoch-Weser S, Porteny T, Rifkin DE, et al. Patient education for kidney failure treatment: a mixed-methods study. Am J Kidney Dis. 2021;78: 690–699.eng
dcterms.referencesFildes K, Stefoska-Needham A, Atkinson J, et al. Optimising health care for people living with chronic kidney disease: health-professional perspectives. J Ren Care. 2022;48:168–176.eng
dcterms.referencesJager KJ, Kovesdy C, Langham R, et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int. 2019;96:1048–1050.eng
dcterms.referencesEwart C, Baharani J, Wilkie M, et al. Patient perspectives and experiences of remote consultations in people receiving kidney care: a scoping review. J Ren Care. 2022;48:143–153.eng
dcterms.referencesBriggs JP, Hostetter T, Powe NR. Catalyzing advocacy and policies for patients with kidney disease. J Am Soc Nephrol. 2023;34:191–192.eng
oaire.versioninfo:eu-repo/semantics/acceptedVersion

Archivos

Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
381 B
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Artículos

Universidad Simón Bolívar: Todos los derechos reservados / Sistema de biblioteca